Induction of pgp3 expression and reversion of the multidrug resistance phenotype in 9-OH-ellipticine-resistant Chinese hamster lung fibroblasts transfected with the MYC oncogene

Biochemical Pharmacology

Volumn 53, Issue 1, 1997, Pages 59-66

  Delaporte, Charlotte ^a   Dautry, François ^a   Jacquemin Sablon, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

MDR reversion; myc; pgp3 expression

Indexed keywords

9 HYDROXYELLIPTICINE; GLYCOPROTEIN P; GYRASE INHIBITOR; ISOPROTEIN; RNA; VINCRISTINE;

ANIMAL CELL; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; LUNG FIBROBLAST; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CRICETINAE; CRICETULUS; DRUG RESISTANCE, MULTIPLE; ELLIPTICINES; GENES, MYC; HUMANS; MICE; P-GLYCOPROTEIN; P-GLYCOPROTEINS; TRANSFECTION;

EID: 0031060685     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00648-X     Document Type: Article

References (24)

1. Salles B, Charcosset J-Y and Jacquemin-Sablon A, Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives. Cancer Treat Rep 66: 327-337, 1982.
2. Delaporte C, Charcosset J-Y and Jacquemin-Sablon A, Effects of verapamil on the cellular accumulations and toxicity of several antitumor drugs in 9-hydroxy-ellipticine resistant cells. Biochem Pharmacol 37: 613-619, 1988.
3. Larsen AK and Jacquemin-Sablon A, Multiple resistance mechanisms in Chinese hamster cells resistant to 9-hydroxyellipticine. Cancer Res 49: 7115-7119, 1989.
4. Chin KW, Ueda K, Pastan I and Gottesman KM, Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255: 459-462, 1992.
5. Delaporte C, Larsen AK, Dautry F and Jacquemin-Sablon A, Influence of myc overexpression on the phenotypic properties of Chinese hamster lung cells resistant to antitumor agents. Exp Cell Res 197: 176-182, 1991.
6. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
7. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lug NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM and Borst P, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462, 1993.
8. Ruetz S and Gros P, Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77: 1071-1081, 1994.
9. Charcosset J-Y, Salles B and Jacquemin-Sablon A, Uptake and cytofluorescence localization of ellipticine derivatives in sensitive and resistant Chinese hamster lung cells. Biochem Pharmacol 32: 1037-1044, 1983.
10. Hsu SI, Lothstein L and Horwitz SB, Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J Biol Chem 264: 12053-12062, 1989.
11. Schinkel AH, Roelofs MEM and Borst P, Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51: 2628-2635, 1991.
12. Roy SN and Horwitz SB, A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res 45: 3856-3863, 1985.
13. Zeheb R, Beittenmiler HF and Horwitz SB. Use of antibodies to probe membrane glycoproteins associated with drugresistant J774.2 cells. Biochem Biophys Res Commun 143: 732-739, 1987.
14. Evan GI, Lewis GK, Ramsay G and Bishop JM, Isolation and monoclonal antibodies specific for human c-myc protooncogene product. Mol Cell Biol 5: 3610-3616, 1985.
15. Le Pecq J-B, Chimiothérapie anticancéreuse, Hermann, Paris, 1978.
16. Nakagawara A, Kadomatsu K, Sato SS, Kohno K, Takano H, Akazawa K, Nose Y and Kuwano M, Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Cancer Res 50: 3043-3047, 1990.
17. Hann RS, Dixit M, Sears RC and Sealy L, The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev 8: 2441-2452, 1994.
18. Croop JM, Raymond M, Haber D, Devault A, Areci RJ, Gros P and Housman DE, The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9: 1346-1350, 1989.
19. Teeter LD, Becker FF, Chisari FV, Li D and Kuo MT, Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Mol Cell Biol 10: 5728-5735, 1990.
20. Teeter LD, Eckersberg T, Tsai Y and Kuo MT, Analysis of the Chinese hamster P-glycoprotein/multidrug resistant pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ 2: 429-437, 1991.
21. Benvenisty N, Leder A, Kuo A and Leder P, An embryonically expressed gene is a target for c-Myc-regulation via the c-Myc-binding sequence. Genes Dev 6: 2513-2523, 1992.
22. Bello-Fernandez C, Packham G and Cleveland JL, The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA 90: 7804-7808, 1993.
23. Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P and Housman DE, The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9: 1346-1350, 1989.
24. Buschman E, Arceci RJ, Croop JM, Che M, Arias IM, Housman DE and Gros P, Mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J Biol Chem 267: 18093-18099, 1992.